KU Hematology & Medical Oncology Review 2019

 

KU Hematology & Medical Oncology Review 2019
W

Management of Toxicities in Neoadjuvant (Perioperative) Chemotherapy in Local-Regional and Neoadjuvant PARPi Therapy in Rectal Cancer

By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
0 views
August 23, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri
Gastrointestinal
14:39
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and …

Feat. R. Al-Rajabi
16:20
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Hepatobiliary Cancer: Pembrolizumab vs. Best…

Feat. R. Al-Rajabi
19:12
KU Hematology & Medical Oncology Review 2019

Management of Toxicities in Neoadjuvant (Perioperative) Chemotherapy…

Feat. W. Sun
18:29
KU Hematology & Medical Oncology Review 2019

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal…

Feat. W. Sun